Koers PHILIPS KON JUN9 Euronext Amsterdam
Aandelen
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 18,7 mld. 20,14 mld. 0 | Omzet 2025 * | 19,67 mld. 21,18 mld. 0 | Marktkapitalisatie | 22,5 mld. 24,23 mld. 0 |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 189 mln. 204 mln. - | Nettowinst (verlies) 2025 * | 1,15 mld. 1,23 mld. - | EV/omzet 2024 * | 1,47 x |
Nettoschuld 2024 * | 4,93 mld. 5,31 mld. 0 | Nettoschuld 2025 * | 4,62 mld. 4,97 mld. 0 | EV/omzet 2025 * | 1,38 x |
K/w-verhouding 2024 * |
123
x | K/w-verhouding 2025 * |
22,2
x | Werknemers | - |
Dividendrendement 2024 * |
3,44% | Dividendrendement 2025 * |
3,62% | Vrij verhandelbaar | 83,91% |
Recentste transcriptie over PHILIPS KON JUN9
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Roy Jakobs
CEO | Chief Executive Officer | 50 | 01-01-10 |
Director of Finance/CFO | 62 | 01-01-87 | |
Shez Partovi
CTO | Chief Tech/Sci/R&D Officer | 57 | 22-03-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 01-01-15 |
Sanjay Poonen
BRD | Director/Board Member | 55 | 01-01-22 |
Director/Board Member | 68 | 01-05-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,73% | 226 mld. | |
+9,53% | 188 mld. | |
+14,63% | 137 mld. | |
+27,47% | 108 mld. | |
-0,04% | 63,19 mld. | |
+13,73% | 52,26 mld. | |
+4,86% | 51 mld. | |
+7,72% | 43,89 mld. | |
+7,86% | 38,07 mld. |